Sfoglia per Autore
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study
2025 Provenzano, L; Dieci, M; Curigliano, G; Giuliano, M; Botticelli, A; Lambertini, M; Rizzo, G; Pedersini, R; Sirico, M; La Verde, N; Gennari, A; Zambelli, A; Toss, A; Piras, M; Giordano, M; Tagliaferri, B; Generali, D; Sartori, D; Miliziano, D; Menichetti, A; Ligorio, F; Zurlo, C; Griguolo, G; Berton Giachetti, P; Faso, V; Corti, C; Chiappe, E; Scagnoli, S; Pisegna, S; Capasso, C; De Angelis, C; Arpino, G; Criscitiello, C; Guarneri, V; Pruneri, G; Mariani, L; Vernieri, C; Bianchini, G; Munzone, E; Marra, A; Boldrini, L; Carnevale Schianca, A; Katrini, J; Cona, M; Cantile, V; Grieco, A; Pirolo, M; Zappulo, M; De Giglio, M; Lagana, M; Cosentini, D; De Giorgi, U; Vingiani, A; Belfiore, A; Fotia, G; Mazzoli, G; Sposetti, C; Abate, A; Bianchessi, V; Capri, G; Bianchi, G; De Braud, F; Baili, P; Scaperrotta, G; Depretto, C; Lasagna, A; Jacobs, F; Ponzoni, O; Maccarone, S; Strina, C; Coccato, S; Coviello, R
Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients
2025 Canzian, J; Gentile, D; De Sanctis, R; Jacobs, F; Benvenuti, C; Gaudio, M; Gerosa, R; Saltalamacchia, G; Torrisi, R; Masci, G; Tinterri, C; Zambelli, A
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway
2025 Gori, S; Fabi, A; Procopio, G; Airoldi, M; Zambelli, A; Lanzetta, G; Bracarda, S; Foglietta, J; Leo, S; Baggi, A; Franzini, J; Valerio, M; Verze, M; Nicolis, F
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer
2025 Lorini, L; Gili, R; Resteghini, C; Gerosa, R; Cecchi, L; Gurizzan, C; Zambelli, A; Zucali, P; Bossi, P
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses
2025 Canzian, J; Conforti, F; Jacobs, F; Benvenuti, C; Gaudio, M; Gerosa, R; De Sanctis, R; Zambelli, A
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists
2025 Gaudio, M; Vatteroni, G; De Sanctis, R; Gerosa, R; Benvenuti, C; Canzian, J; Jacobs, F; Saltalamacchia, G; Rizzo, G; Pedrazzoli, P; Santoro, A; Bernardi, D; Zambelli, A
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates
2025 Pala, L; Merlo, F; Sala, I; Pagan, E; Oriecuia, C; Specchia, C; Catania, C; Cocorocchio, E; Laszlo, D; Ceresoli, G; Locatelli, M; De Pas, T; Zambelli, A; Cortes, J; Giaccone, G; Moore, K; Bardia, A; Viale, G; Gelber, R; Bagnardi, V; Conforti, F
Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer
2024 De Sanctis, R; Tiberio, P; Jacobs, F; Gaudio, M; Benvenuti, C; Giordano, L; Torrisi, R; Zambelli, A; Pozzi, C; Penna, G; Santoro, A; Rescigno, M
Corrigendum to “Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 204 (2024) 104527](S1040842824002701)(10.1016/j.critrevonc.2024.104527)
2024 Belloni, S; Tiberio, P; De Sanctis, R; Magon, A; Santoro, A; Zambelli, A; Caruso, R; Arrigoni, C
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study
2024 Cazzaniga, M; Pronzato, P; Amoroso, D; Bernardo, A; Biganzoli, L; Bisagni, G; Blasi, L; Bria, E; Cognetti, F; Crinò, L; De Laurentiis, M; Del Mastro, L; De Placido, S; Beano, A; Ferraù, F; Foladore, S; Forcignanò, R; Gamucci, T; Garrone, O; Gennari, A; Giordano, M; Giotta, F; Giovanardi, F; Latini, L; Livi, L; Marchetti, P; Mattioli, R; Michelotti, A; Montemurro, F; Putzu, C; Riccardi, F; Ricciardi, G; Romagnoli, E; Sarobba, G; Spazzapan, S; Tagliaferri, P; Tinari, N; Tonini, G; Turletti, A; Verusio, C; Zambelli, A; Mustacchi, G
Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer – A Clinical Review
2024 Benvenuti, C; Grinda, T; Rassy, E; Dixon-Douglas, J; Ribeiro, J; Zambelli, A; Santoro, A; Pistilli, B
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer
2024 Gaudio, M; Jacobs, F; Benvenuti, C; Saltalamacchia, G; Gerosa, R; De Sanctis, R; Santoro, A; Zambelli, A
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients
2024 Giordani, E; Allegretti, M; Sinibaldi, A; Michelotti, F; Ferretti, G; Ricciardi, E; Ziccheddu, G; Valenti, F; Di Martino, S; Ercolani, C; Giannarelli, D; Arpino, G; Gori, S; Omarini, C; Zambelli, A; Bria, E; Paris, I; Buglioni, S; Giacomini, P; Fabi, A
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
2024 Conforti, F; Pala, L; De Pas, T; Zattarin, E; Catania, C; Cocorocchio, E; Rossi, G; Laszlo, D; Colleoni, M; Zambelli, A; Hortobagyi, G; Cortes, J; Piccart, M; Dowsett, M; Gelber, R; Viale, G
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer
2024 Saltalamacchia, G; Torrisi, R; De Sanctis, R; Masci, G; Miggiano, C; Gaudio, M; Benvenuti, C; Jacobs, F; Gerosa, R; Santoro, A; Zambelli, A
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors
2024 Antonini, S; Pedersini, R; Birtolo, M; Baruch, N; Carrone, F; Jaafar, S; Ciafardini, A; Cosentini, D; Lagana, M; Torrisi, R; Farina, D; Leonardi, L; Balzarini, L; Vena, W; Bossi, A; Zambelli, A; Lania, A; Berruti, A; Mazziotti, G
The interaction of patients’ physical status and time to endoscopy on mortality risk in patients with upper gastrointestinal bleeding: A national prospective cohort study
2024 Bucci, C; Marmo, C; Soncini, M; Riccioni, M; Laursen, S; Gralnek, I; Marmo, R; Amitrano, L; Anderloni, A; Andriulli, A; Annese, V; Baldassarre, G; Bargiggia, S; Balzano, A; Bazzoli, F; Bennato, R; Bianco, M; Bizzotto, A; Boarino, V; Bonanomi, A; Borgheresi, P; Bresci, G; Buffoli, F; Buscarini, E; Castrignanò, G; Cavallaro, L; Cesaro, P; Chirico, A; Cipolletta, F; Cipolletta, L; Conigliaro, R; Conte, D; Costamagna, G; Covello, F; D'Amico, G; De Fanis, C; De Filippo, F; de Franchis, R; Dell‘era, A; De Nigris, F; De Matthaeis, M; Di Giorgio, P; Di Giulio, E; Esposito, P; Ferraris, L; Filippino, A; Franceschi, M; Furio, L; Germana', B; Grassia, R; Imperiali, G; Lamanda, R; Lauri, A; Londoni, C; Mangiafico, S; Manno, M; Marmo, C; Merighi, A; Meroni, R; Metrangolo, S; Montalbano, L; Napolitano, G; Nucci, A; Orsini, L; Parente, F; Parravicini, M; Paterlini, A; Pumpo, R; Purita, L; Repici, A; Riccioni, M; Russo, A; Segato, S; Sorrentino, I; Spinzi, G; Spotti, D; Tortora, A; Tomba, C; Triossi, O; Zagari, R; Zambelli, A
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
2024 Gerosa, R; De Sanctis, R; Jacobs, F; Benvenuti, C; Gaudio, M; Saltalamacchia, G; Torrisi, R; Masci, G; Miggiano, C; Agustoni, F; Pedrazzoli, P; Santoro, A; Zambelli, A
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis
2024 Belloni, S; Tiberio, P; Sanctis, R; Magon, A; Santoro, A; Zambelli, A; Caruso, R; Arrigoni, C
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort
2024 Gelardi, F; Cavinato, L; De Sanctis, R; Ninatti, G; Tiberio, P; Rodari, M; Zambelli, A; Santoro, A; Fernandes, B; Chiti, A; Antunovic, L; Sollini, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile